Skip to main content

Table 3 Socio demographic, obstetric and knowledge characteristics associated with IPTp-SP uptake

From: Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya

Independent variables

All N = 372 n (%), Mean ± SD

Uptake of IPTp-SP

P-value

Optimal N = 296 n (%), Mean ± SD

Sub-optimal N = 76 n (%), Mean ± SD

Maternal age (years), mean(± SD)

26.3 ± 5.7

27.5 ± 5.8

25.3 ± 5.4

0.1

Age category

 15–24 years

160 (43.0)

121 (40.9)

39 (51.3)

0.29

 25–34 years

173 (46.5)

142 (48.0)

31 (40.8)

  ≥ 35 years

39 (10.5)

33 (11.1)

6 (7.9)

Marital status

 Unmarried

87 (23.4)

62 (20.9)

25 (32.9)

0.04a

 Married

285 (76.6)

234 (79.1)

51 (67.1)

Woman's Education level

 Primary

142 (38.2)

108 (36.5)

34 (44.8)

0.48

 Secondary

178 (47.8)

145 (49.0)

33 (43.4)

 Tertiary

52 (14.0)

43 (14.5)

9 (11.8)

Woman's Employment status

 Not employed

252 (67.7)

193 (65.2)

59 (77.6)

0.17

 Informal employment

95 (25.6)

82 (27.7)

13 (17.1)

 Formal employment

25 (6.7)

21 (7.1)

4 (5.3)

Religion

 Catholic

20 (5.4)

13 (4.4)

7 (9.2)

0.15

 Protestant

350 (94.1)

282 (95.3)

68 (89.5)

 Muslim

2 (0.5)

1 (0.3)

1 (1.3)

Ward of Residence

 Busali

85 (22.9)

68 (23.0)

17 (22.4)

0.84

 Wodanga

49 (13.2)

37 (12.5)

12 (15.8)

 North Maragoli

31 (8.3)

24 (8.1)

7 (9.2)

 Chavakali

64 (17.2)

52 (17.6)

12 (15.8)

 Sabatia West

60 (16.1)

46 (15.5)

14 (18.4)

 Lyaduywa Izava

83 (22.3)

69 (23.3)

14 (18.4)

Residence

 Rural

287 (77.2)

224 (75.7)

63 (82.9)

0.16

 Urban

85 (22.8)

72 (24.3)

13 (17.1)

Gestation age at 1st ANC visit

  ≤ 16 weeks

197 (53.0)

179 (60.5)

18 (23.7)

 < 0.001a

  > 16 weeks

175 (47.0)

117 (39.5)

58 (76.3)

Frequency of ANC visits

  < 4 visits

84 (22.6)

33 (11.2)

51 (67.1)

 < 0.001a

  ≥ 4 visits

288 (77.4)

263 (88.8)

25 (32.9)

Parity

 1 child

142 (38.2)

108 (36.5)

34 (44.7)

0.41

 2 children

82 (22.0)

66 (22.3)

16 (21.1)

 3+ children

148 (39.8)

122 (41.2)

26 (34.2)

Experience of SP side effects

 No

197 (53.0)

154 (52.0)

43 (56.6)

0.29

 Yes

173 (46.5)

142 (48.0)

31 (40.8)

 Not applicable

2 (0.5)

0

2 (2.6)

Knowledge of MiP dangers

 Unknowledgeable

112 (30.1)

89 (30.1)

23 (30.3)

0.97

 Low knowledge

136 (36.5)

110 (37.2)

26 (34.2)

 Moderate knowledge

94 (25.3)

73 (24.6)

21 (27.6)

 Adequate knowledge

30 (8.1)

24 (8.1)

6 (7.9)

Knowledge of MiP prevention

 Unknowledgeable

5 (1.3)

4 (1.4)

1 (1.3)

0.86

 Low knowledge

216 (58.1)

168 (56.7)

48 (63.2)

 Moderate knowledge

128 (34.4)

104 (35.1)

24 (31.6)

 Adequate knowledge

23 (6.2)

20 (6.8)

3 (3.9)

Knowledge of IPTp-SP benefits

 Poor

77 (20.7)

50 (16.9)

27 (35.5)

 < 0.001a

 Good

295 (79.3)

246 (83.1)

49 (64.5)

Knowledge of IPTp-SP start

 Poor

318 (85.5)

252 (85.1)

66 (86.8)

0.67

 Good

54 (14.5)

44 (14.9)

10 (13.2)

Knowledge of optimal SP dose

 Poor

183 (49.2)

135 (45.6)

48 (63.2)

0.01a

 Good

189 (50.8)

161 (53.4)

28 (36.8)

  1. aStatistically significant result at 5% significance level. ANC: Antenatal care; IPTp-SP: Intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine; SD: Standard Deviation; SP: Sulphadoxine pyrimethamine